Urík Milan, Šikolová Soňa, Hošnová Dagmar, Kruntorád Vít, Bartoš Michal
Department of Pediatric Otorhinolaryngology University Hospital Brno Brno Czech Republic.
Faculty of Medicine Masaryk University Brno Brno Czech Republic.
Laryngoscope Investig Otolaryngol. 2023 Feb 23;8(2):591-598. doi: 10.1002/lio2.1030. eCollection 2023 Apr.
The young population requires early rehabilitation of their hearing loss for normal cognitive, auditive hence social development. All of which, in turn, may have an impact on quality of life (QoL). This study aims to evaluate QoL between two different bone conduction (BC) hearing devices: a noninvasive adhesive hearing aid (Adhear [ADH]) vs. an active transcutaneous implant (Bonebridge [BB]).
This study composed of 12 BB and 15 ADH users. Pure tone as well as speech in noise and quiet measurements were evaluated and compared to the Assessment in QoL questionnaire (AQoL-6d).
Freefield results showed significant improvements for both devices compared to the unaided condition ( < .0001). Emphasis needs to be drawn on the different unaided level of conductive hearing loss as well as the indication range for both evaluated device groups: the ADH subjects exhibited a mean BC value of 9.50 ± 7.96 dB HL (the indication range up to 25 dB) and the BB subjects a mean of 23.33 ± 25.66 dB HL (the indication range up to 45 dB). Speech perception in quiet and in noise was significantly improved ( < .05; < .001, respectively). QoL was significantly improved for both treatments ( < .05) but was not different among the devices, and the values were similar to their normal hearing, age, and sex-matched control group. High correlations were found between QoL utility scores and improved PTA4 in the aided condition ( = .8839 and .7810 for BB and ADH, respectively).
Our results show that both devices offer significant beneficial audiological rehabilitations with significantly increased QoL. However, the underlying condition and the unaided degree of hearing loss, hence the required higher stimulation must be the deciding factor when opting for a hearing device, and this should be independent of age.
2c.
年轻人群需要对其听力损失进行早期康复,以实现正常的认知、听觉及社会发展。而所有这些反过来又可能对生活质量(QoL)产生影响。本研究旨在评估两种不同的骨传导(BC)听力设备之间的生活质量:一种无创粘性助听器(Adhear [ADH])与一种有源经皮植入物(骨桥 [BB])。
本研究由12名BB使用者和15名ADH使用者组成。对纯音以及噪声和安静环境下的言语进行评估,并与生活质量问卷(AQoL - 6d)进行比较。
自由场结果显示,与未佩戴助听器的情况相比,两种设备均有显著改善(P <.0001)。需要强调的是传导性听力损失的不同未佩戴助听器水平以及两个评估设备组的适用范围:ADH受试者的平均骨传导值为9.50±7.96 dB HL(适用范围高达25 dB),BB受试者的平均骨传导值为23.33±25.66 dB HL(适用范围高达45 dB)。安静和噪声环境下的言语感知均有显著改善(分别为P <.05;P <.001)。两种治疗方法的生活质量均有显著改善(P <.05),但两种设备之间无差异,且数值与年龄、性别匹配的正常听力对照组相似。在佩戴助听器的情况下,生活质量效用评分与改善的PTA4之间存在高度相关性(BB和ADH的r分别为.8839和.7810)。
我们的结果表明,两种设备均提供了显著有益的听力学康复效果,生活质量显著提高。然而,潜在病情和听力损失的未佩戴助听器程度,以及因此所需的更高刺激,在选择听力设备时必须是决定因素,且这应与年龄无关。
2c。